ACRS - Aclaris Therapeutics, Inc.
IEX Last Trade
3.01
0.065 2.159%
Share volume: 13,758
Last Updated: Thu 26 Dec 2024 08:29:10 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$2.94
0.07
2.21%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-08 | 2023-02-23 | 2023-05-08 | 2023-08-07 | 2023-11-06 | 2024-02-27 | 2024-05-07 | |
| Total revenue | 1.528 M | 19.018 M | 7.753 M | 2.528 M | 1.869 M | 9.282 M | 17.570 M | 2.398 M | |
| Cost of revenue | 1.068 M | 923.000 K | 877.000 K | 808.000 K | 1.042 M | 848.000 K | 725.000 K | 809.000 K | |
| Gross profit | 460.000 K | 18.095 M | 6.876 M | 1.720 M | 827.000 K | 8.434 M | 16.845 M | 1.589 M | |
| 3,833.70% | -62.00% | -74.99% | -51.92% | 919.83% | 99.73% | -90.57% | |||
| Operating expenses | 24.854 M | 29.469 M | 28.218 M | 31.377 M | 33.592 M | 30.967 M | 34.860 M | 16.689 M | |
| Selling general and admin | 6.075 M | 5.813 M | 7.146 M | 8.790 M | 8.317 M | 7.091 M | 8.214 M | 6.844 M | |
| Research and development | 18.779 M | 23.656 M | 21.072 M | 22.587 M | 25.275 M | 23.876 M | 26.646 M | 9.845 M | |
| Total expenses | 25.922 M | 30.392 M | 29.095 M | 32.185 M | 34.634 M | 31.815 M | 41.288 M | 18.529 M | |
| 17.24% | -4.27% | 10.62% | 7.61% | -8.14% | 29.78% | -55.12% | |||
| Operating income | -24.394 M | -11.374 M | -21.342 M | -29.657 M | -32.765 M | -22.533 M | -23.718 M | -16.131 M | |
| Ebit | -24.394 M | -11.374 M | -21.342 M | -29.657 M | -32.765 M | -22.533 M | -23.718 M | -16.131 M | |
| Pretax income | -20.532 M | -19.952 M | -27.635 M | -28.160 M | -29.569 M | -29.261 M | -1.858 M | -16.941 M | |
| -2.82% | 38.51% | 1.90% | 5.00% | -1.04% | -93.65% | 811.79% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -367.000 K | 0.000 | |
| Net income basic | -20.532 M | -19.952 M | -27.635 M | -28.160 M | -29.569 M | -29.261 M | -1.491 M | -16.941 M | |
| 2.82% | -38.51% | -1.90% | -5.00% | 1.04% | 94.90% | -1,036.22% | |||
| Net income | -20.532 M | -19.952 M | -27.635 M | -28.160 M | -29.569 M | -29.261 M | -1.491 M | -16.941 M | |
| 2.82% | -38.51% | -1.90% | -5.00% | 1.04% | 94.90% | -1,036.22% |